Bcl-2 Monoclonal Antibody, 100ul Serological Pipets BCAS2 was identified through differential

BCAS2 was identified through differential display analysis as an mRNA species that was overexpressed in MCF7 and BT-20 breast cancer cell lines

and RNA splicing (Miranda et al

platelet type 8 (BDPLT8)

The products have an effective filtration area of up to 19

also known as ATPBD3 (ATP-binding domain-containing protein 3) or NCS6

Bcl-2 Monoclonal Antibody, 100ul Serological Pipets BCAS2 was identified through differentialThis gene encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Alternative splicing results in multiple transcript variants.